Trials / Completed
CompletedNCT04371328
Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection
Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection (Unit "COVID Possible")
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,860 (actual)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
This research aims to improve knowledge of the epidemiology of patients consulting in the COvid Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in "intermediate" patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. It will be necessary to identify the diagnosis of the dyspneic patient and to define his virological status COVID before referring him to the appropriate units. The investigatory propose an original strategy of dedicating entire care sectors to the care of patients admitted for dyspnea in our ER. These units will be named RECOP units. This study would improve epidemiological knowledge of COVID-19 and ability to receive these patients within the SU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | RECOP unit patient | All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified. 30 days after inclusion, virological status and mortality will be collect |
Timeline
- Start date
- 2020-03-13
- Primary completion
- 2020-06-05
- Completion
- 2020-06-30
- First posted
- 2020-05-01
- Last updated
- 2021-10-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04371328. Inclusion in this directory is not an endorsement.